/
Senators Get Update on Administration’s Classification System Reform Efforts
Published on
Senators Get Update on Administration’s Classification System Reform Efforts

Sens. Ron Wyden, D-Ore., and Jerry Moran, R-Kan., announced that the White House is leading an effort to reform the classification system as stated by Director of National Intelligence Avril Haines, a two-time Wash100 Award recipient, in a letter. 

Haines said in the letter that agencies are taking part in a White House-led process that seeks to gather insights on challenges related to the standardization of information management, declassification, classification and the control of sensitive data.

The DNI letter was in response to a call by Wyden and Moran for the Biden administration to update the executive order that establishes rules for government classification and declassification to address urgent concerns in the current system that undermine national security.

“I’m pleased that the Biden administration is committed to reforming the classification system and investing in new declassification technology. I’ll continue watching closely to ensure the White House gets it done and ultimately heeds my call to update the executive order governing classification,” Wyden said in a statement published Wednesday.

Haines also informed the lawmakers of current efforts within the Intelligence Community to improve the declassification process.

/
DIU Seeks Proposals for Blockchain-Based Data Protection Tech Development Program
Published on
DIU Seeks Proposals for Blockchain-Based Data Protection Tech Development Program

The Defense Innovation Unit has asked vendors to propose commercial technologies that would enable the integration of components on a Web3 or Blockchain platform designed to ensure the security of data within a federated data system.

DIU said the proposed system should allow for cross-domain or classification-level sharing, use quantum-resistant cryptography, support the use of the common access card, operate as an on-premises platform, integrate with managed service offerings and leverage distributed learning capabilities across domains.

The platform should be deployed on existing hardware systems, include plans to support role-based access control in the future and integrate entity-related application systems using commodity hardware, encryption and cryptographic data structures. 

“We expect a minimal viable product to be delivered in the form of data storage, authorized access, and classification level-based access control,” the DIU notice reads.

Proposals are due Nov. 11.

//
Pentagon Unveils National Defense Strategy, Nuclear Posture, Missile Defense Reviews; Lloyd Austin Quoted
Published on
Pentagon Unveils National Defense Strategy, Nuclear Posture, Missile Defense Reviews; Lloyd Austin Quoted

The Department of Defense has issued the public versions of the National Defense Strategy, Nuclear Posture Review and the Missile Defense Review, DOD News reported Thursday.

“By weaving these documents together, we help ensure that the entire department is moving forward together, matching our resources to our goals,” Defense Secretary Lloyd Austin, a 2022 Wash100 Award winner, said in a statement published Thursday.

The 2022 National Defense Strategy highlights the need to strengthen deterrence against China and cites the threats posed by Russia, Iran, North Korea and violent extremist organizations.

The NDS also outlines DOD’s four top defense priorities: defending the homeland, paced to the growing multidomain threat posed by China; deterring strategic attacks against the U.S., allies and partners; deterring aggression while being prepared to prevail in conflict when necessary; and building a resilient joint force and defense ecosystem.

Gen. Austin said the strategy cites integrated deterrence, campaigning and measures that build enduring advantages as ways to advance those priorities.

The 2022 Nuclear Posture Review will advance several measures to ensure a secure and effective deterrent while reducing the role of nuclear weapons in U.S. strategy. These include adopting a strategy and declaratory policy that maintain a very high bar for nuclear employment; taking steps to strengthen extended deterrence and allied assurance; retiring the B83-1 gravity bomb; and canceling the nuclear-armed Sea-Launched Cruise Missile program.

The 2022 Missile Defense Review calls for the U.S. to continue to invest in the development of missile defeat capabilities to maintain deterrence and cites the need for the country’s Integrated Air and Missile Defense posture to be comprehensive, mobile, layered and ready to counter adversary missiles.

“To be most effective, it must also be integrated and interoperable with Allies and partners, and underpinned with increasingly robust domain awareness capabilities within a pliable missile defense network,” the document reads.

USSOCOM Seeks Mobile Workstation Concepts
Published on
USSOCOM Seeks Mobile Workstation Concepts

The U.S. Special Operations Command is interested in working with vendors to design, build and test mobile workstations for the transportation of military personnel and server storage to mission areas.

SOCOM said in a notice posted on SAM.gov that SOFWERX, a public-private innovation factory that helps connect industry with military programs, will host a three-day virtual assessment event in January for interested offerors to present their ideas for the support truck prototype project.

The command is seeking three workstations that can accommodate at least four passengers and six racks of server storage, supply multiple internal and external 20A 120 volts alternating current power receptacles and feature a climate-controlled work environment.

The selection process is divided into four phases, with the last phase culminating in federal acquisition regulation or non-FAR contracts with partners that meet SOCOM requirements. 

The main virtual assessment event will run from Jan. 3 to Jan. 5 where selected participants will have the chance to pitch and demonstrate proposals through a one-on-one session with a SOCOM panel of assessors.

Interested parties can submit their concepts for the mobile workstations from Oct. 28 to Nov. 28. Following a review of the submissions, proposers who meet the requirements will receive an invitation to the event on or around Dec. 9. 

//
DMI Acquires Ambit Group to Expand Portfolio Within Federal Market; CEO Sunny Bajaj Quoted
Published on
DMI Acquires Ambit Group to Expand Portfolio Within Federal Market; CEO Sunny Bajaj Quoted

DMI, the digital transformation services organization, has acquired data analytics, cybersecurity and mission support company Ambit Group in an undisclosed transaction.

The acquisition will advance DMI’s collection of digital services and extend its customer and contract vehicle portfolio within federal markets, the Bethesda, Maryland-based company stated on Thursday.

“With this addition, we combine Ambit’s comprehensive data management, analytics, and cybersecurity services with our cross-industry, digital transformation expertise to help drive the next generation of digital government,” DMI founder and CEO Sunny Bajaj commented.

Bajaj also emphasized the high demand for IT modernization and new technological innovations.

DMI offers enterprise consulting, transformation and maintenance services to both public and private sector clients. The company uses a streamlined suit of agile software development and engineering solutions powered by business strategy, domain-specific knowledge and technical prowess.

With a focus on federal agencies, Ambit targets the area of mission performance development by providing digital enhancement services across the areas of homeland security, regulatory and civilian services.

“With Ambit’s track record of success in this space, coupled with DMI’s extensive experience and range of services, this pairing represents an unstoppable force,” said Ambit co-CEO Kim Hayes.

The company has worked in the fields of finance, national security, and science with a variety of federal clients including the Securities and Exchange Commission, Federal Emergency Management Agency and the Consumer Financial Protection Bureau.

/
Akima Infrastructure Services Receives $63M Award to Bolster Operations at Two DOE Nuclear Facilities
Published on
Akima Infrastructure Services Receives $63M Award to Bolster Operations at Two DOE Nuclear Facilities

Akima Infrastructure Services, a subsidiary of Akima, has secured a potential four-year, $63 million, from Consolidated Nuclear Security, to enhance staff proficiency in engineering, professional and technical services for the Department of Energy.

The agreement covers two of the department’s facilities, the Y-12 National Security Complex in Oak Ridge, Tennessee and its Pantex Plant in Amarillo, Texas, which are crucial in managing the U.S. nuclear supply, the Herndon, Virginia-based company announced on Thursday.

The Y-12 National Security Complex handles the production, surveillance, dismantlement and storage of nuclear assets. Additional operations at the facility are designed to reduce global nuclear threats by identifying, discarding and protecting nuclear material.

Duncan Greene, president of Akima’s Mission Systems, Engineering and Technology group commented on the company’s history of support for the DoE’s mission.

 “This award from CNS will allow us to continue this partnership and provide the DOE with support to operate critical nuclear security facilities effectively and efficiently,” he stated.

Akima received this award under the CNS Engineering Professional and Technical Basic Ordering Agreement through the DOE Integrated Contractor Purchasing team to consolidate procurement processes and reduce the cost of ownership for the department’s contractors.

Consolidated Nuclear Security is composed of various member companies within the realm of government contracting. The organization works to reinforce the efforts of the National Nuclear Security Administration.

//
CISA Names Former Microsoft Specialist Matt House as CDM Program Manager
Published on
CISA Names Former Microsoft Specialist Matt House as CDM Program Manager

Matt House, a former modern work specialist within Microsoft‘s U.S. federal civilian business unit, has been appointed program manager of the Cybersecurity and Infrastructure Security Agency’s Continuous Diagnostics and Mitigation initiative.

In this role, House will collaborate with federal agencies and industry on deploying cybersecurity tools, dashboards and integration services designed to secure federal networks against threats, according to CISA’s LinkedIn post.

House brings more than two decades of industry experience in areas such as program management, software engineering, cybersecurity and information technology.

He has previously supported government-wide efforts across the Department of Homeland Security, including the implementation of the EINSTEIN intrusion detection system and the CDM dashboard.

House served as director of cybersecurity services at InfoReliance and vice president of the technology solutions business unit at EGlobalTech.

/
Pentagon to Establish New Office to Oversee JADC2 Integration Efforts
Published on
Pentagon to Establish New Office to Oversee JADC2 Integration Efforts

The Department of Defense has announced a new office responsible for aligning the efforts of the Navy, Army and Air Force to enable multidomain warfighting capabilities, DefenseNews reported Wednesday.

The acquisition, integration and interoperability office will operate under the Office of the Secretary of Defense and work to ensure that the services’ contributions to the Joint All Domain Command and Control initiative work across air, sea, land, space and cyber domains.

Chris O’Donnell, deputy assistant secretary of defense for platform and weapon portfolio management, said the office will look at how to fully integrate the multibillion-dollar effort across the department and work toward achieving “more jointness” among the services.

“I would never say the services are too siloed in their approach. The services are doing exactly what they need to support service needs,” O’Donnell said.

The Army supports the JADC2 effort through its Project Convergence networking and technology experiment, while the Air Force has the Advanced Battle Management System and the Navy has Project Overmatch.

/
Navy, Army Conduct Hypersonic Weapon Flight Campaign
Published on
Navy, Army Conduct Hypersonic Weapon Flight Campaign

The U.S. Navy and Army have launched a precision-sounding rocket to test various experiments to guide the development of next-generation offensive and defensive hypersonic weapon systems.

Sandia National Laboratories conducted the flight campaign at NASA’s Wallops Flight Facility in Virginia to inform the Navy’s Conventional Prompt Strike and the Army’s Long Range Hypersonic Weapon programs, the Navy said Wednesday.

Data collected from the test will guide the development of a Navy-designed common hypersonic missile that both services will use alongside individual weapon systems and sea and land-based launchers.

The sounding rocket contained hypersonic experiments and prototypes from several defense contractors and partners including Mitre, Johns Hopkins University Applied Physics Laboratory and Oak Ridge National Laboratory.

The U.S. military use sounding rockets to speed up the maturation of weapon technologies before going through the final design stage.

The Missile Defense Agency also participated in the flight campaign to gather data for its weapon development program to counter hypersonic missile threats.

Moderna Inc. Leaders and Executives: Who Are They?
Published on
Moderna Inc. Leaders and Executives: Who Are They?

Moderna Inc. is best known for developing the COVID-19 vaccine. The company has extensive mRNA solutions, which it uses in its 46 products in the pipeline and 36 products in ongoing clinical trials. Learn more about Moderna Inc. leaders and executives right here.

About Moderna Inc.

About Moderna Inc.

Moderna is a pharmaceutical and biotechnology company with a big focus on harnessing the power of mRNA. The company has scored a total of $2.48 billion in federal agency funding research for developing COVID-19 vaccines and securing doses for the government. Moderna Inc. has played a transformative role in the medical world amid the pandemic.

History of Moderna Inc.

Messenger RNA is a big part of Moderna’s history. Since its founding in 2010, the company has used the technology to develop vaccines for influenza, HIV, respiratory syncytial virus, chikungunya, and more. Check the breakthroughs of Moderna Inc. over the past decade.

  • In 2010, Moderna was born by combining the words “modified” and “RNA” to form the word “modern.”
  • In 2014, Moderna expanded in new its headquarters in Cambridge, Massachusetts.
  • In 2015, Moderna developed the first-in-human dose flu vaccine through mRNA-1440.
  • In 2017, Moderna developed the first-in-human dosing for mRNA-1653, a multivalent vaccine that can cure more than one disease at the same time.
  • In 2019, Moderna’s first antibody encoded by mRNA is in a clinical trial.
  • In 2022, The U.S. Food and Drug Administration (FDA) fully approves Moderna’s COVID-19 vaccine (SPIKEVAX) for at least 18 years old.

Who are the Founders of Moderna?

Moderna Inc. was founded in Cambridge, Massachusetts, where the company still headquarters today. A team of four founded the company, namely:

  • Robert Langer, a renowned bioengineering professor at MIT and founder of controlled-release drug delivery and tissue engineering fields
  • Derrick Rossi, an assistant professor at the Stem Cell and Regenerative Biology Department of Harvard Medical School and the accredited innovator of the mRNA technology of Moderna
  • Kenneth Chien, an appointee of Stockholm’s Karolinska Institute and Harvard’s Stem Cell and Regenerative Biology Department
  • Noubar Afeyan, a venture capitalist who is the sole institutional investor of Moderna, a biochemical engineer, and Chief Executive Officer of Flagship Ventures

Who is the Head of Moderna?

Since October 2011, the head of Moderna is Stéphane Bancel, who serves as the Chief Executive Officer. He leads over 3,000 team members in changing the world of medicine with mRNA. As the head of the company, he oversees and implements the company’s values: bold, relentless, collaborative, and curious.

Who are the Moderna Executives?

Moderna Inc. believes in diversity and inclusion in the workplace.  They encourage and reward employees for their curiosity, collaboration, and agility. Meet the executive team of Moderna Inc.

Stéphane Bancel, Chief Executive Officer

Stéphane Bancel, Chief Executive Officer

Stéphane Bancel serves as the Chief Executive Officer (CEO) of Moderna Inc. He’s been a part of the company’s board of directors since March 2011. He oversees all company operations and encourages the use of Mindsets tools to build the best possible version of Modena 20 years down the line.

Before becoming Moderna Inc. CEO, Bancel served as the Chief Executive Officer of bioMérieux SA for five years. He also worked at Eli Lilly and Company as Managing Director of Belgium and Executive Director of Global Manufacturing Strategy and Supply Chain.

Stephen Hoge, M.D., President

Stephen Hoge, M.D., President

Stephen Hoge, M.D., has served as Moderna’s President and Head of Research since 2015. He heads all the company’s research and development initiatives, focusing primarily on basic science, clinical development, regulatory, and therapeutic areas.

Previously, Dr. Hoge worked as the company’s Senior Vice President of Corporate Development for New Drug Concepts and Oncology from December 2012 to December 2014. Before joining Moderna’s executive team, he worked as a partner at McKinsey & Company.

Paul Burton, M.D., Chief Medical Officer

Paul Burton, M.D., Chief Medical Officer

Paul Burton, M.D., is responsible for Moderna’s medical affairs and safety as the Chief Medical Officer. He has over 20 years of experience in the industry, with board certification in surgery and specialist training in cardiothoracic surgery. He also has a Ph.D. in cardiovascular molecular and cellular biology.

Burton’s previous works before Moderna include Chief Global Medical Affairs Officer, Vice President, Head of Cardiovascular and Metabolic Medical Affairs at Janssen Pharmaceuticals, and Senior Medical Director at Johnson & Johnson.

Jerh Collins, Ph.D., Chief Technical Operations and Quality Officer

Jerh Collins, Ph.D., Chief Technical Operations and Quality Officer

Jerh Collins, Ph.D., is responsible for Moderna’s portfolio of technical development, quality, and programs for preclinical, clinical, and commercial supplies as the Chief Technical Operations and Quality Officer. He recently joined Moderna’s executive team in October 2022.

Previously, Dr. Collins worked at Novartis for nearly 30 years, where he served as Chief Culture Officer, Head of Global Chemical Operations and Anti-Infectives, and Head of API Manufacturing Pharma. His earlier work was as a chemist at Merck & Co.

Kate Cronin, Chief Brand Officer

Kate Cronin, Chief Brand Officer

Kate Cronin has served as Moderna Inc.’s Chief Brand Officer since July 2021. Her key responsibilities are brand and creative strategy, strategic communications, social media, leadership, and integrated marketing. She has been in charge of Moderna’s branding and introducing the promise of mRNA science technology to the public.

In her tenure at the company, she was named ‘Top 15 People to Watch‘ by PRovoke in 2022 and ranked in the ‘100 Most Inspiring People’ by PharmaVoice in 2021. Previously, she served as the Global Chief Executive Officer at Ogilvy Health and founded the company’s Women’s Leadership Professional Network.

Marcello Damiani, Chief Digital and Operational Excellence Officer

Marcello Damiani, Chief Digital and Operational Excellence Officer

Marcello Damiani is the Chief Digital and Operational Excellence Officer of Moderna Inc. He has been instrumental in managing the company’s tech, life science, and IT teams since joining in May 2015. He is an expert at strategizing, monitoring, and implementing innovative programs for the digital space.

Damiani has worked with different multinational companies across the U.S. and Europe for more than 30 years. Some of his senior leadership roles include Senior Vice President, Chief Information Officer, Executive Director of IT Global Infrastructure Services at bioMérieux and Senior Director of Global Networks at Motorola.

Tracey Franklin, Chief Human Resources Officer

Tracey Franklin, Chief Human Resources Officer

Tracy Franklin heads Moderna’s talent and organizational strategy as the Chief Human Resources Officer. She has years of experience in human resources operations and global talent management in Europe, including the U.K. and Ireland, the Middle East, Africa, and Canada.

Previously, Franklin worked at Merck & Co. for over 15 years, where she headed the company’s global talent strategy as Vice President and Chief of Human Resources Talent and Strategy Officer. She built an extensive portfolio in the vision, development, and execution of talent and workforce strategies and organizational culture.

Arpa Garay, Chief Commercial Officer

Arpa Garay, Chief Commercial Officer

Arpa Garay is the Chief Commercial Officer at Moderna Inc. She is responsible for the company’s global commercial organization, corporate strategy, business development, data & analytics, and company digital transformation. She assumed office in May 2022.

Garay has over 20 years of healthcare and global general management experience across commercial profit and loss. Previously, she worked as Chief Marketing Officer at Merck & Co., Inc. and held responsibilities across oncology, vaccines, specialty, chronic care, and more.

Jamey Mock, Chief Financial Officer

Jamey Mock, Chief Financial Officer

Jamey Mock joined Moderna Inc. as the Chief Financial Officer in September 2022. Previously, he worked as the Senior Vice President and CFO at PerkinElmer, Inc., Vice President of Corporate Audit Staff at General Electronics, and CFO at Subsea Systems & Drilling for GE Oil & Gas.

As Moderna Inc. CFO, Mock oversees the company’s financial, business development, and other business services functions. He also serves on the Executive Committee and reports directly to the Chief Executive Officer, Stéphane Bancel.

Shannon Thyme Klinger, Chief Legal Officer and Corporate Secretary

Shannon Thyme Klinger, Chief Legal Officer and Corporate Secretary

Shannon Thyme Klinger leads Moderna’s legal, governance, and corporate compliance efforts as the Chief Legal Officer and Corporate Secretary. She has also served as the President of Moderna Charitable Foundation since June 2021.

Klinger’s previous senior leadership positions include Chief Legal Officer, Chief Ethics, Risk & Compliance Officer, Global Head of Litigation, and General Counsel at Novartis, where she worked for over ten years. She focuses on driving long-term business performance and ensuring society’s access to medicine.

Juan Andres, President of Strategic Partnerships and Enterprise Expansion

Juan Andres, President of Strategic Partnerships and Enterprise Expansion

Juan Andres serves as the President of Strategic Partnerships and Enterprise Expansion at Moderna. He heads the company’s growth organizations in the mRNA pipeline. He first joined the business in 2017 as the Chief Technical Operations and Quality Officer.

Before joining the company, Andres held the Global Head of Technical Operations, Manufacturing, and Supply Chain position at Novartis, where he headed over 25,000 employees across divisions. He also worked at Eli Lilly & Co. for 18 years and was involved in manufacturing, production, and quality roles.

Who is Moderna Inc. Board of Directors?

Moderna Inc. leadership members also include the board of directors, composed of established executives in their respective fields. They are key decision markers, creating policies and important solutions in the company. Meet the company’s Board of Directors here.

  • Noubar Afeyan, Ph.D., Co-founder & Chairman of Moderna and Chief Executive Officer of Flagship Pioneering
  • Stéphane Bancel, Chief Executive Officer of Moderna
  • Stephen Berenson, Managing Partner of Flagship Pioneering
  • Sandra Horning M.D., Co-founder & Advisor of EQRx
  • Robert Langer Sc.D., Academic Co-Founder of Moderna and David H. Koch Institute Professor at MIT
  • Elizabeth (Betsy) Nabel M.D., Executive Vice President for Strategy at ModeX Therapeutics
  • François Nader M.D., Former President, Chief Executive Officer, & Executive Director of NPS Pharmaceuticals
  • Paul Sagan, Senior Advisor and Executive-in-Residence of General Catalyst
  • Elizabeth Tallett, Former Principal of Hunter Partners

Changing The World of Medicine With The Power of mRNA

With a promise to deliver the power of mRNA, Moderna Inc. leaders and executives are changing the world of medicine. Under the leadership of Chief Executive Officer Stéphane Bancel, the company commits to world-class drug discovery and developments in biotechnology.

1 … 740 741 742 743 744 … 2,659